The Scientist TOP TEN INNOVATIONS: the Prosigna Breast Cancer Prognostic Gene Signature Assay ranks 4th

In a tight competition to rank the top ten innovations for 2013, The Scientist recently published its definitive list.

The Prosigna Breast Cancer Progonostic Gene Signature Assay ranked 4th and Aleix Prat, Principal Investigator of VHIO´s Translational Genomics Group, was subsequently invited to comment based on his experience working with the Nanostring assay.

Click here to view the Top 10 Innovations for 2013.

Related Posts

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.